Log in

Relevant bibliographies by topics / Ruthenium-dmso / Journal articles

To see the other types of publications on this topic, follow the link: Ruthenium-dmso.

Journal articles on the topic 'Ruthenium-dmso'

Author: Grafiati

Published: 1 April 2023

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Ruthenium-dmso.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Saadh, Mohamed. "Anticancer and antiproliferative activity of ruthenium complex (II) bearing 3,3’-dicarboxy-2,2’-bipyridine ligand." Pharmacia 70, no. 3 (2023): 803–7. http://dx.doi.org/10.3897/pharmacia.70.e111508.

Full text

Abstract:

Even though significant progress has been made in cancer treatment, there is always room for improvement. The experimental drug Ruthenium Complex II shows promise as a cancer treatment. In this article, the dichloro-3,3’-dicarboxy-2,2’-bipyridyl bis(dimethylsulphoxide)ruthenium(II) [RuCl2(3,3’-dcbpy)(DMSO)2], have been synthesized, characterized, and studied for its anticancer activity against MDA-MB-231 and MRC-5 cell lines, as well as its mechanisms of action and selectivity. According to research, [RuCl2 (3,3’-dcbpy)(DMSO)2], is highly cytotoxic to the MDA-MB-231 and minimum cytotoxic to MR

APA, Harvard, Vancouver, ISO, and other styles

2

Chandra, Manish, D. Shankar Pandey, M. Carmen Puerta та Pedro Valerga. "Ap-cymene-ruthenium(II)–DMSO complex, [(η6-C10H14)RuCl2(DMSO)]". Acta Crystallographica Section E Structure Reports Online 58, № 1 (2001): m28—m29. http://dx.doi.org/10.1107/s1600536801021237.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Saadh, Mohamed. "Anticancer and antiproliferative activity of ruthenium complex (II) bearing 3,3'-dicarboxy-2,2'-bipyridine ligand." Pharmacia 70, no. (3) (2023): 803–7. https://doi.org/10.3897/pharmacia.70.e111508.

Full text

Abstract:

Even though significant progress has been made in cancer treatment, there is always room for improvement. The experimental drug Ruthenium Complex II shows promise as a cancer treatment. In this article, the dichloro-3,3'-dicarboxy-2,2'-bipyridyl bis(dimethylsulphoxide)ruthenium(II) [RuCl<sub>2</sub>(3,3'-dcbpy)(DMSO)<sub>2</sub>], have been synthesized, characterized, and studied for its anticancer activity against MDA-MB-231 and MRC-5 cell lines, as well as its mechanisms of action and selectivity. According to research, [RuCl<sub>2</sub> (3,3'-dcbpy)(DMSO)<sub>2</sub>], is highly cytotoxic t

APA, Harvard, Vancouver, ISO, and other styles

4

Zhu, Dengsen, Cong Zhao, Xuesong Wang, Wenji Wang, Baohuai Wang, and Weihong Du. "Roles of DMSO-type ruthenium complexes in disaggregation of prion neuropeptide PrP106–126." RSC Advances 6, no. 19 (2016): 16055–65. http://dx.doi.org/10.1039/c5ra21523d.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Jaswal, Jaswinder S., Steven J. Rettig, and Brian R. James. "Ruthenium(III) complexes containing dimethylsulfoxide or dimethylsulfide ligands, and a new route to trans-dichlorotetrakis(dimethylsulfoxide)ruthenium(II)." Canadian Journal of Chemistry 68, no. 10 (1990): 1808–17. http://dx.doi.org/10.1139/v90-282.

Full text

Abstract:

The new Ru(III) complex tran-[(dmso)2H]+[RuCl4(dmso)2]− (1) (dmso = S-bonded dimethylsulfoxide) has been synthesized. New synthetic routes are reported for mer-RuX3(dms)3 complexes (dms = dimethylsulfide, X = Cl (2) and Br (3)) and for trans-RuCl2(dmso)4 (4). The complexes have been studied spectroscopically while 1, 2 and 4 have also been characterized crystallographically. Crystals of 1 are monoclinic, P2/n, a = 9.280(3), b = 16.518(4), c = 14.034(3) Å, β = 100.78(2)°, Z = 4, ρc = 1.75 g cm−3. Crystals of 2 are orthorhombic, Pca21a = 10.764(2), b = 11.375(1), c = 12.243(1) Å, Z = 4, ρc = 1.7

APA, Harvard, Vancouver, ISO, and other styles

6

Messori, Luigi, Felix Kratz, and Enzo Alessio. "The Interaction of the Antitumor Complexes Na[trans-RuCl4(DMSO)(Im)] and Na[trans-RuCl4(DMSO)(Ind)] With Apotransferrin: a Spectroscopic Study." Metal-Based Drugs 3, no. 1 (1996): 1–9. http://dx.doi.org/10.1155/mbd.1996.1.

Full text

Abstract:

The interaction of two antitumor ruthenium(III) complexes,-Na[trans-RuCl4(DMSO)(Im)] and Na[trans-RuCl4(DMSO)(Ind)]- with human serum apotransferrin (apoTf) was investigated through a number of spectroscopic techniques such as UV-Vis absorption, CD and H1 NMR spectroscopy. Interestingly, the hydrolysis profiles of these complexes in a physiological buffer are markedly affected by the presence, in solution, of apoTf suggesting the occurrence of a specific interaction of their respective hydrolysis products with the protein. The formation of stable adducts with apotransferrin has been demonstrat

APA, Harvard, Vancouver, ISO, and other styles

7

Kljun, Jakob, Saša Petriček, Dušan Žigon, Rosana Hudej, Damijan Miklavčič, and Iztok Turel. "Synthesis and Characterization of Novel Ruthenium(III) Complexes with Histamine." Bioinorganic Chemistry and Applications 2010 (2010): 1–6. http://dx.doi.org/10.1155/2010/183097.

Full text

Abstract:

Novel ruthenium(III) complexes with histamine[RuCl4(dmso-S)(histamineH)]⋅O(1a) and[RuCl4(dmso-S)(histamineH)](1b) have been prepared and characterized by X-ray structure analysis. Their crystal structures are similar and show a protonated amino group on the side chain of the ligand which is not very common for a simple heterocyclic derivative such as histamine. Biological assays to test the cytotoxicity of the compound1bcombined with electroporation were performed to determine its potential for future medical applications in cancer treatment.

APA, Harvard, Vancouver, ISO, and other styles

8

Rachford, Aaron A., Jeffrey L. Petersen, and Jeffrey J. Rack. "Efficient Energy Conversion in Photochromic Ruthenium DMSO Complexes." Inorganic Chemistry 45, no. 15 (2006): 5953–60. http://dx.doi.org/10.1021/ic0603398.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Groot, Broer de, Hilary A. Jenkins, Stephen J. Loeb, and Shannon L. Murphy. "Ruthenium(II) complexes of the thiacyclophane ligands 2,5,8-trithia[9]-o-cyclophane (TT[9]OC) and 5-oxa-2,8-dithia[9]-o-cyclophane (ODT[9]OC). Structures of RuCl2(DMSO)(TT[9]OC) and RuCl2(PPh3)(ODT[9]OC)." Canadian Journal of Chemistry 73, no. 7 (1995): 1102–10. http://dx.doi.org/10.1139/v95-136.

Full text

Abstract:

Ruthenium(II) complexes of the thiacyclophane ligands 2,5,8-trithia[9]-o-cyclophane (TT[9]OC) and 5-oxa-2,8-dithia[9]-o-cyclophane (ODT[9]OC) were synthesized by ligand displacement reactions employing RuCl2(DMSO)4, RuCl2(PPh3)3, and RuHCl(PPh3)3 as starting materials. X-ray crystal structures of two of these complexes, RuCl2(DMSO)(TT[9]OC) and RuCl2(PPh3)(ODT[9]OC), demonstrate how TT[9]OC and ODT[9]OC bind to Ru(II). RuCl2(DMSO)(TT[9]OC) crystallized as the DMSO solvate in the orthorhombic space group Pbca with a = 19.590(5), b = 16.849(4), c = 13.149(4) Å, V = 4340(3) Å3, and Z = 8. The str

APA, Harvard, Vancouver, ISO, and other styles

10

Motswainyana, William M., and Peter A. Ajibade. "Anticancer Activities of Mononuclear Ruthenium(II) Coordination Complexes." Advances in Chemistry 2015 (February 19, 2015): 1–21. http://dx.doi.org/10.1155/2015/859730.

Full text

Abstract:

Ruthenium compounds are highly regarded as potential drug candidates. The compounds offer the potential of reduced toxicity and can be tolerated in vivo. The various oxidation states, different mechanism of action, and the ligand substitution kinetics of ruthenium compounds give them advantages over platinum-based complexes, thereby making them suitable for use in biological applications. Several studies have focused attention on the interaction between active ruthenium complexes and their possible biological targets. In this paper, we review several ruthenium compounds which reportedly posses

APA, Harvard, Vancouver, ISO, and other styles

11

Turel, Iztok, Milena Pecanac, Amalija Golobic, Enzo Alessio, Barbara Serli, and Alberta Bergamo. "Ruthenium(III)-DMSO complexes of the antiherpes drug acyclovir." Journal of Inorganic Biochemistry 96, no. 1 (2003): 241. http://dx.doi.org/10.1016/s0162-0134(03)80789-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Zimmermann, Teresa K., Stefan Haslinger, Alexander Pöthig та Fritz E. Kühn. "Structure and catalytic activity of the ruthenium(I) sawhorse-type complex [Ru2{μ,η2-CF3(CF2)5COO}2(DMSO)2(CO)4]". Acta Crystallographica Section C Structural Chemistry 70, № 4 (2014): 384–87. http://dx.doi.org/10.1107/s2053229614006354.

Full text

Abstract:

The title compound,cis-di-μ-perfluoroheptanoato-κ4O:O′-bis[dicarbonyl(dimethyl sulfoxide-κS)ruthenium(I)](Ru—Ru), [Ru2(C7F13O2)2(C2H6OS)2(CO)4], is a sawhorse-type dinuclear ruthenium complex with two bridging perfluoroheptanoate ligands, and with two dimethyl sulfoxide (DMSO) ligands in the axial positions coordinatingviathe S atoms. It is a new example of a compound with an aliphatic fluorinated carboxylate ligand. The Ru—Ru bond distance of 2.6908 (3) Å indicates a direct Ru—Ru interaction. The compound is an active catalyst in transvinylation of propionic acid with vinyl acetate.

APA, Harvard, Vancouver, ISO, and other styles

13

Chan, Peter K. L., Paul K. H. Chan, David C. Frost, Brian R. James, and Kirsten A. Skov. "Ruthenium (II) complexes of 4-nitroimidazoles: their characterization, solution chemistry, and radiosensitizing activity." Canadian Journal of Chemistry 66, no. 1 (1988): 117–22. http://dx.doi.org/10.1139/v88-018.

Full text

Abstract:

A series of ruthenium(II) complexes of formulation RuCl2(dmso)2Ln, where dmso = S-bonded dimethylsulfoxide, L is a 4-nitroimidazole derivative, and n = 1 or 2, have been synthesized and characterized by spectroscopic methods, particularly 1H nmr and X-ray photoelectron spectroscopy. With L = 4-nitroimidazole itself (4-NO2Im), RSU-1170, -3083 or -3100, n = 2 and the six-coordinate complexes are considered to be of cis,cis,cis-geometry. The N-methyl-4-nitroimidazole (NMe-4-NO2Im) ligand (n = 1) chelates through the imidazole-N and the oxygen of NO2. The RSU-3159 ligand (n = 1) binds through the

APA, Harvard, Vancouver, ISO, and other styles

14

Ducrocq, Guillaume P., Juan A. Estrada, Joyce S. Kim, and Marc P. Kaufman. "Blocking the transient receptor potential vanilloid-1 does not reduce the exercise pressor reflex in healthy rats." American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 317, no. 4 (2019): R576—R587. http://dx.doi.org/10.1152/ajpregu.00174.2019.

Full text

Abstract:

Controversy exists regarding the role played by transient receptor potential vanilloid-1 (TRPV1) in evoking the exercise pressor reflex. Here, we determine the role played by TRPV1 in evoking this reflex while assessing possible confounding factors arising from TRPV1 antagonists or from the vehicle in which they were dissolved. The exercise pressor reflex was evoked in decerebrated, anesthetized Sprague-Dawley rats by electrical stimulation of the tibial nerve to contract the triceps surae muscles statically. This procedure was repeated before and after injection of the TRPV1 blockers: capsaze

APA, Harvard, Vancouver, ISO, and other styles

15

Sharutin, V., O. Sharutina, and V. Senchurin. "Synthesis and Structure of Ruthenium Complexes [Ph4P][trans-RuCl4(dmso-S)2] and [Ph4Sb(dmso-O)][trans-RuCl4(dmso-S)2]." «Bulletin of the South Ural State University series "Chemistry"» 9, no. 2 (2017): 58–64. http://dx.doi.org/10.14529/chem170208.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Osman, Ahmed H., Waleed A. El-Said, and M. Abd El-Shakour. "Synthesis and characterization of some new ruthenium (II) complexes as photosensitizers in dye-sensitized solar cells." JOURNAL OF ADVANCES IN CHEMISTRY 12, no. 5 (2017): 4413–26. http://dx.doi.org/10.24297/jac.v12i5.6265.

Full text

Abstract:

New ruthenium (II) complexes, [Ru(DHZ)2(bpy)], [Ru(SCN)2(bpy)(DMSO)2], [Ru(SCN)2(dmbpy)(DMSO)2] and [RuCl2(salen)]-2, where bpy = 2,2'- bipyridine, DHZ = 1,5-diphenylthiocarbazone, dmbpy = 4,4'-dimethyl-2,2' bipyridine and salen = 2,2'- ethylenebis(nitrilomethylidene)diphenol were synthesized and characterized by elemental analysis, FTIR, UV-Vis spectroscopy and thermal analysis. From data of these investigations the structural formula and the mode of bonding were obtained. These complexes were successfully applied to sensitization of nano-crystalline TiO2 based solar cells (DSSCs). The photov

APA, Harvard, Vancouver, ISO, and other styles

17

P., Hazarika, J. Deka, S. Bhola, R. K. Bhola, C. Medhi, and O. K. Medhi. "DNA binding properties and biological studies of cis-dichloro tetrakis(dimethylsulphoxide)ruthenium(II) complex." International Journal of Drug Design and Discovery 3, no. 4 (2025): 907–13. https://doi.org/10.37285/ijddd.3.4.4.

Full text

Abstract:

The [Ru(DMSO)4Cl2] is a well known compound among the ruthenium complexes. Here, we report a unique binding of this compound with Calf Thymus DNA (CT-DNA) by spectroscopic and electrophoresis studies. The biological studies of this compound carried out in vivo and in vitro experiments on mice bearing with Daltonâ€™s lymphoma were performed. The six co-ordinated [Ru(DMSO)4Cl2] complex was prepared and the structure has been characterized by FT-IR, 1H NMR and x-ray diffraction studies. The evidences of DNA binding by this complex have been indicated from fluorescence, UV-visible and electrophore

APA, Harvard, Vancouver, ISO, and other styles

18

Bi, Lihua, Firasat Hussain, Ulrich Kortz, Masahiro Sadakane, and Michael H. Dickman. "A novel isopolytungstate functionalized by ruthenium: [HW9O33RuII2(dmso)6]7?" Chemical Communications, no. 12 (2004): 1420. http://dx.doi.org/10.1039/b403902e.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Schleicher, David, Hendrik Leopold та Thomas Strassner. "Ruthenium(II) DMSO complexes with CˆC* cyclometalated phenylimidazol NHC ligands". Journal of Organometallic Chemistry 829 (лютий 2017): 101–7. http://dx.doi.org/10.1016/j.jorganchem.2016.10.036.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Chan, P. K. L., K. A. Skov, B. R. James, and N. P. Farrell. "A new ruthenium radiosensitizer: RuC12(DMSO)2(4-Nitroimidazole)2." International Journal of Radiation Oncology*Biology*Physics 12, no. 7 (1986): 1059–62. http://dx.doi.org/10.1016/0360-3016(86)90225-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Al-Wahish, Mohammed A., Mohamed Saadh, and Ali H. Salama. "Synthesis, characterization and antibacterial activity of ruthenium complex bearing 3,3’-dicarboxy-2,2’-bipyridine ligand." Pharmacia 70, no. 2 (2023): 405–10. http://dx.doi.org/10.3897/pharmacia.70.e103053.

Full text

Abstract:

The development of bacteria has been one of the most significant advances in medical science. The need for the development of novel antibacterial is clear, but the development of new antibacterial classes is more important. In this study, the new ruthenium complex bearing the NN chelating ligand 3,3’-dicarboxy-2,2’-bipyridine (3,3’-dcbpy) and the dimethylsulphoxide (DMSO) ligand, [Ru(3,3’-dcbpy) (DMSO)2Cl2], was synthesized and characterized using FT-IR, 1H- and 13C-NMR spectroscopy, elemental analysis, and UV-Vis spectrometry. In addition, the Ru-complex was examined for its activity as an an

APA, Harvard, Vancouver, ISO, and other styles

22

Rohmann, Kai, Jens Kothe, Matthias W. Haenel, Ulli Englert, Markus Hölscher, and Walter Leitner. "Hydrogenation of CO2to Formic Acid with a Highly Active Ruthenium Acriphos Complex in DMSO and DMSO/Water." Angewandte Chemie International Edition 55, no. 31 (2016): 8966–69. http://dx.doi.org/10.1002/anie.201603878.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Rohmann, Kai, Jens Kothe, Matthias W. Haenel, Ulli Englert, Markus Hölscher, and Walter Leitner. "Hydrogenation of CO2to Formic Acid with a Highly Active Ruthenium Acriphos Complex in DMSO and DMSO/Water." Angewandte Chemie 128, no. 31 (2016): 9112–15. http://dx.doi.org/10.1002/ange.201603878.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Sava, G., G. Salerno, A. Bergamo, et al. "Reduction of Lung Metastases by Na[trans-RuCl4(DMSO)Im] is not Coupled With the Induction of Chemical Xenogenization." Metal-Based Drugs 3, no. 2 (1996): 67–73. http://dx.doi.org/10.1155/mbd.1996.67.

Full text

Abstract:

The effects of the treatment of tumor cells of MCa mammary carcinoma and TLX5 lymphoma with the ruthenium complex Na[trans-RuCl4(DMSO)lm] for several transplant generations were studied on tumor growth and metastases formation. On TLX5 lymphoma cells, treatment was performed in vitro prior to in vivo inoculation of tumor cells in intact or immunesuppressed mice. Either considering tumor take and growth or its capacity to invade the brain of the inoculated hosts, Na[trans-RuCl4(DMSO)lm] did not induce any significant modification. Conversely, in mice with MCa mammary carcinoma, the in vivo trea

APA, Harvard, Vancouver, ISO, and other styles

25

Zhang, Si-Qi, Li-Hua Gao, Hua Zhao, and Ke-Zhi Wang. "Recent Progress in Polynuclear Ruthenium Complex-Based DNA Binders/Structural Probes and Anticancer Agents." Current Medicinal Chemistry 27, no. 22 (2020): 3735–52. http://dx.doi.org/10.2174/0929867326666181203143422.

Full text

Abstract:

Ruthenium complexes have stood out by several mononuclear complexes which have entered into clinical trials, such as imidazolium [trans-RuCl4(1H-imidazole)(DMSO-S)] (NAMI-A) and ([Ru(II)(4,4&#039;-dimethyl-2,2&#039;-bipyridine)2-(2(2&#039;-,2&#039;&#039;:5&#039;&#039;,2&#039;&#039;&#039;-terthiophene)-imidazo[4,5-f] [1,10]phenanthroline)] 2+) (TLD-1433), opening a new avenue for developing promising ruthenium-based anticancer drugs alternative to Cisplatin. Polynuclear ruthenium complexes were reported to exhibit synergistic and/or complementary effects:

APA, Harvard, Vancouver, ISO, and other styles

26

Al-Wahish, Mohammed A., Mohamed Saadh, and Ali H. Salama. "Synthesis, characterization and antibacterial activity of ruthenium complex bearing 3,3'-dicarboxy-2,2'-bipyridine ligand." Pharmacia 70, no. (2) (2023): 405–10. https://doi.org/10.3897/pharmacia.70.e103053.

Full text

Abstract:

The development of bacteria has been one of the most significant advances in medical science. The need for the development of novel antibacterial is clear, but the development of new antibacterial classes is more important. In this study, the new ruthenium complex bearing the NN chelating ligand 3,3'-dicarboxy-2,2'-bipyridine (3,3'-dcbpy) and the dimethylsulphoxide (DMSO) ligand, [Ru(3,3'-dcbpy) (DMSO)<sub>2</sub>Cl<sub>2</sub>], was synthesized and characterized using FT-IR, <sup>1</sup>H- and <sup>13</sup>C-NMR spectroscopy, elemental analysis, and UV-Vis spectrometry. In addition, the Ru-co

APA, Harvard, Vancouver, ISO, and other styles

27

Vielma, Joel, Jose Cardenas, Bernardo Fontal, et al. "Study of catalytic activity on hydrogenation reactions of 1-hexene by RuCl2(Py)4 and RuCl2(DMSO)2(NC5H4CO2Na)2 supported on functionalized MCM-48." Avances en Química 13, no. 3 (2019): 49–54. http://dx.doi.org/10.53766/avanquim/2018.13.03.01.

Full text

Abstract:

Two hybrid catalysts were synthesized: (I) from dichlorotetrakis(pyridine)ruthenium(II) [RuCl2(Py)4] and (II) cisdichlorobis (dimetylsulfoxide)bis(sodiumnicotinate)ruthenium(II) [RuCl2(DMSO)2(NC5H4CO2Na)2] supported on MCM-48 functionalized, using post-synthesis method with [3-(2-aminoethylamino)propyl]trimethoxysilane and triethoxymethylsilane as anchoring and passivation ligands, respectively. The catalysts were characterized using infrared spectroscopy (FTIR), mass spectrometry (MS), thermogravimetric analysis (TGA-DSC), nitrogen adsorptiondesorption, scanning electron microscopy and energy

APA, Harvard, Vancouver, ISO, and other styles

28

Batista, Alzir A., Salete L. Queiroz, Peter C. Healy, et al. "A novel coordination mode for a pyridylphosphine ligand. X-ray structures of [RuCl2(NO)L] (I) and [RuCl2(NO)L]·DMSO (II) (L = [(2-py)2PC2H4POO(2-py)2]-)." Canadian Journal of Chemistry 79, no. 5-6 (2001): 1030–35. http://dx.doi.org/10.1139/v01-038.

Full text

Abstract:

The ruthenium(II) complex, [RuCl2(NO)L] (I), (L = [(2-py)2PC2H4PO2(2-py)]-) was obtained from recrystallization of RuCl3NO(d2pype) (d2pype = (2-py)2PC2H4P(2-py)2) in the presence of HNO3, crystallizing in the monoclinic space group P21 (no. 4), with a = 8.012(4) Å, b = 14.454(4) Å, c = 9.353(3) Å, β = 105.77(3)°, and Z = 2. Crystals of the DMSO solvate of the complex (II) were obtained from (CD3)2SO solution, crystallizing in the monoclinic space group P21/c (no.14) with a = 9.7080(2) Å, b = 22.2920(5) Å, c = 11.5230(3) Å, β = 92.0450(10)°, and Z = 4. In both complexes, the geometry about the

APA, Harvard, Vancouver, ISO, and other styles

29

Anderson, Craig, and André L. Beauchamp. "1H NMR study of the solvolysis of the paramagnetic tetrachloro-bis(imidazole)ruthenium(III) anion in water, methanol, and dimethyl sulfoxide." Canadian Journal of Chemistry 73, no. 4 (1995): 471–82. http://dx.doi.org/10.1139/v95-062.

Full text

Abstract:

The 1H NMR signals of the Ru(III) species present in solution are considerably broadened and shifted by paramagnetism, but they can be used to follow chloride displacement in the trans-[RuCl4Im2]− ion. This anion remains predominant for several hours at room temperature in D2O, but its signals are progressively replaced by those of a monoaqua [RuCl3(D2O)Im2] complex. Over a period of days, two new sets of peaks appear, corresponding to two isomers of [RuCl2(D2O)2Im2]+. The same behaviour is observed for the 1-methyl-and 4-methylimidazole analogues. These reactions can be driven backwards by ad

APA, Harvard, Vancouver, ISO, and other styles

30

Coluccia, M., G. Sava, G. Salerno, et al. "Efficacy of 5-FU Combined to Na[trans-RuCl4(DMSO)Im] , A Novel Selective Antimetastatic Agent, on the Survival Time of Mice With P388 Leukemia, P388/DDP subline and MCa Mammary Carcinoma." Metal-Based Drugs 2, no. 4 (1995): 195–99. http://dx.doi.org/10.1155/mbd.1995.195.

Full text

Abstract:

The combinational treatment between the selective antimetastatic agent, sodium-trans-rutheniumtetrachloridedimethylsulfoxideimidazole, Na[trans-RuCl4(DMSO)Im], and the cytotoxic drug 5-fluorouracil (5-FU) on primary tumor growth and on the survival time of experimental tumors results in an effect significantly greater than that of each single agent used alone either with the solid metastasizing MCa mammary carcinoma of the CBA mouse or with the lymphocytic leukemia P388 and its platinum resistant P388/DDP subline. Thus the inorganic compound Na[trans-RuCl4(DMSO)Im], known for its potent and se

APA, Harvard, Vancouver, ISO, and other styles

31

Sarma, Uma Charan, K. P. Sarma, and Raj K. Poddar. "Complexes of Ruthenium(III) with dimethylsulphoxide—I. [Ru2Cl6(DMSO)4], fac and mer isomers of [RuCl3(DMSO)3]: Versatile starting materials for the synthesis of ruthenium(III) complexes." Polyhedron 7, no. 18 (1988): 1727–35. http://dx.doi.org/10.1016/s0277-5387(00)80404-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Alessio, Enzo, and Luigi Messori. "NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry." Molecules 24, no. 10 (2019): 1995. http://dx.doi.org/10.3390/molecules24101995.

Full text

Abstract:

NAMI-A ((ImH)[trans-RuCl4(dmso-S)(Im)], Im = imidazole) and KP1019/1339 (KP1019 = (IndH)[trans-RuCl4(Ind)2], Ind = indazole; KP1339 = Na[trans-RuCl4(Ind)2]) are two structurally related ruthenium(III) coordination compounds that have attracted a lot of attention in the medicinal inorganic chemistry scientific community as promising anticancer drug candidates. This has led to a considerable amount of studies on their respective chemico-biological features and to the eventual admission of both to clinical trials. The encouraging pharmacological performances qualified KP1019 mainly as a cytotoxic

APA, Harvard, Vancouver, ISO, and other styles

33

Nielsen, Vance G. "Phosphate-Buffered Saline and Dimethyl Sulfoxide Enhance the Antivenom Action of Ruthenium Chloride against Crotalus atrox Venom in Human Plasma—A Preliminary Report." International Journal of Molecular Sciences 25, no. 12 (2024): 6426. http://dx.doi.org/10.3390/ijms25126426.

Full text

Abstract:

Ruthenium chloride (RuCl3) is widely utilized for synthesis and catalysis of numerous compounds in academia and industry and is utilized as a key molecule in a variety of compounds with medical applications. Interestingly, RuCl3 has been demonstrated to modulate human plasmatic coagulation and serves as a constituent of a compounded inorganic antivenom that neutralizes the coagulopathic effects of snake venom in vitro and in vivo. Using thrombelastography, this investigation sought to determine if RuCl3 inhibition of the fibrinogenolytic effects of Crotalus atrox venom could be modulated by ve

APA, Harvard, Vancouver, ISO, and other styles

34

Bi, Li-Hua, Bin Wang, Guang-Feng Hou, Bao Li, and Li-Xin Wu. "A novel heptatungstovanadate fragment stabilized by organo-ruthenium group: [HVW7O28Ru(dmso)3]6−." CrystEngComm 12, no. 11 (2010): 3511. http://dx.doi.org/10.1039/c0ce00087f.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Yamamura, Tomoya, Hiroshi Nakatsuka, Shinji Tanaka, and Masato Kitamura. "Asymmetric Hydrogenation oftert-Alkyl Ketones: DMSO Effect in Unification of Stereoisomeric Ruthenium Complexes." Angewandte Chemie International Edition 52, no. 35 (2013): 9313–15. http://dx.doi.org/10.1002/anie.201304408.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Yanagisawa, Masaru, Ferenc Korodi, Jianjun He, Licheng Sun, Villy Sundström, and Björn Åkermark. "Ruthenium phthalocyanines with axial carboxylate ligands: Synthesis and function in solar cells based on nanocrystalline TiO2." Journal of Porphyrins and Phthalocyanines 06, no. 03 (2002): 217–24. http://dx.doi.org/10.1142/s1088424602000257.

Full text

Abstract:

The synthesis and characterization of phthalocyaninato-ruthenium ( PcRu ) complexes with potential functional axial ligands are described. The solubility of these PcRu complexes was much improved compared to their parent phthalocyanines without Ru , enabling purification by normal flash column chromatography and also NMR measurements in common solvents (e. g. DMSO - d 6 and CDCl 3). Adsorption of these phthalocyanine dyes onto the surface of a semiconductor through the carboxyl group(s) in the axial ligands prevents to some extent formation of H-aggregates, which is typical for phthalocyanines

APA, Harvard, Vancouver, ISO, and other styles

37

Cruz, Thais R., Rodolpho A. N. Silva, Antonio E. H. Machado, Benedito S. Lima-Neto, Beatriz E. Goi, and Valdemiro P. Carvalho. "New dmso–ruthenium catalysts bearing N-heterocyclic carbene ligands for the ring-opening metathesis of norbornene." New Journal of Chemistry 43, no. 16 (2019): 6220–27. http://dx.doi.org/10.1039/c9nj00810a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Ponnusamy, Selvakumar, and Narayanasamy Ramasamy. "In vitro cytotoxicity and antibacterial studies of ruthenium(II) DMSO complexes with S-allyldithiocarbazate." International Journal of Materials and Product Technology 55, no. 1/2/3 (2017): 142. http://dx.doi.org/10.1504/ijmpt.2017.084958.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Ponnusamy, Selvakumar, and Narayanasamy Ramasamy. "In vitro cytotoxicity and antibacterial studies of ruthenium(II) DMSO complexes with S-allyldithiocarbazate." International Journal of Materials and Product Technology 55, no. 1/2/3 (2017): 142. http://dx.doi.org/10.1504/ijmpt.2017.10005667.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Bi, Li-Hua, Ulrich Kortz, Bineta Keita, and Louis Nadjo. "The ruthenium(ii)-supported heteropolytungstates [Ru(dmso)3(H2O)XW11O39]6−(X = Ge, Si)." Dalton Trans., no. 20 (2004): 3184–90. http://dx.doi.org/10.1039/b409232e.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Yamamura, Tomoya, Hiroshi Nakatsuka, Shinji Tanaka, and Masato Kitamura. "Asymmetric Hydrogenation of tert ‐Alkyl Ketones: DMSO Effect in Unification of Stereoisomeric Ruthenium Complexes." Angewandte Chemie 125, no. 35 (2013): 9483–85. http://dx.doi.org/10.1002/ange.201304408.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Trotter, Kasey, Navamoney Arulsamy та Elliott Hulley. "Crystal structure ofcis,fac-{N,N-bis[(pyridin-2-yl)methyl]methylamine-κ3N,N′,N′′}dichlorido(dimethyl sulfoxide-κS)ruthenium(II)". Acta Crystallographica Section E Crystallographic Communications 71, № 9 (2015): m169—m170. http://dx.doi.org/10.1107/s2056989015014875.

Full text

Abstract:

The reaction of dichloridotetrakis(dimethyl sulfoxide)ruthenium(II) withN,N-bis[(pyridin-2-yl)methyl]methylamine affords the title complex, [RuCl2(C13H15N3)(C2H6OS)]. The asymmetric unit contains a well-ordered complex molecule. TheN,N-bis[(pyridin-2-yl)methyl]methylamine (bpma) ligand binds the cation through its two pyridyl N atoms and one aliphatic N atom in a facial manner. The coordination sphere of the low-spind6RuIIis distorted octahedral. The dimethyl sulfoxide (dmso) ligand coordinates to the cation through its S atom and iscisto the aliphatic N atom. The two chloride ligands occupy t

APA, Harvard, Vancouver, ISO, and other styles

43

Alessio, E., M. Bolle, B. Milani, et al. "Carbonyl Derivatives of Chloride-Dimethyl Sulfoxide-Ruthenium(III) Complexes: Synthesis, Crystal Structure, and Reactivity of [(DMSO)2H][trans-RuCl4(DMSO-O)(CO)] and mer,cis-RuCl3(DMSO-O)2(CO)." Inorganic Chemistry 34, no. 19 (1995): 4716–21. http://dx.doi.org/10.1021/ic00123a003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Toyama, Mari, Ryuji Suganoya, Daisuke Tsuduura, and Noriharu Nagao. "Syntheses and Crystal Structures of Mono(di-2-pyridylamine)chloro(dimethyl sulfoxide-S)ruthenium(II) Complexes [RuCl2(Hdpa)(dmso-S)2] and [RuCl(Hdpa)(dmso-O)(dmso-S)2](OTf)." Bulletin of the Chemical Society of Japan 80, no. 5 (2007): 922–36. http://dx.doi.org/10.1246/bcsj.80.922.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Mondal, Ashaparna, and Priyankar Paira. "Synthesis and Biological Evaluations of Organoruthenium Scaffolds: A Comprehensive Update." Current Organic Synthesis 15, no. 2 (2018): 179–207. http://dx.doi.org/10.2174/1570179414666170703143049.

Full text

Abstract:

Background: Currently ruthenium complexes are immerging as effective anticancer agents due to their less toxicity, better antiproliferative and antimetastatic activity, better stability in cellular environment and most importantly variable oxidation and co-ordination states of ruthenium allows binding this molecule with a variety of ligands. So in past few years researchers have shifted their interest towards organoruthenium complexes having good fluorescent profile that may be applicable for cancer theranostics. Nowadays, photodynamic therapy has become more acceptable because of its easy and

APA, Harvard, Vancouver, ISO, and other styles

46

Alagesan, M., P. Sathyadevi, P. Krishnamoorthy, N. S. P. Bhuvanesh, and N. Dharmaraj. "DMSO containing ruthenium(ii) hydrazone complexes: in vitro evaluation of biomolecular interaction and anticancer activity." Dalton Trans. 43, no. 42 (2014): 15829–40. http://dx.doi.org/10.1039/c4dt01032a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Wang, Lei, Lele Duan, Beverly Stewart, et al. "Toward Controlling Water Oxidation Catalysis: Tunable Activity of Ruthenium Complexes with Axial Imidazole/DMSO Ligands." Journal of the American Chemical Society 134, no. 45 (2012): 18868–80. http://dx.doi.org/10.1021/ja309805m.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Turel, Iztok, Milena Pečanac, Amalija Golobič, et al. "Solution, solid state and biological characterization of ruthenium(III)-DMSO complexes with purine base derivatives." Journal of Inorganic Biochemistry 98, no. 2 (2004): 393–401. http://dx.doi.org/10.1016/j.jinorgbio.2003.12.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Tan, Caiping, Sheng Hu, Jie Liu, and Liangnian Ji. "Synthesis, characterization, antiproliferative and anti-metastatic properties of two ruthenium–DMSO complexes containing 2,2′-biimidazole." European Journal of Medicinal Chemistry 46, no. 5 (2011): 1555–63. http://dx.doi.org/10.1016/j.ejmech.2011.01.074.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Demoro, Bruno, Andreia Bento-Oliveira, Fernanda Marques, et al. "Interaction with Blood Proteins of a Ruthenium(II) Nitrofuryl Semicarbazone Complex: Effect on the Antitumoral Activity." Molecules 24, no. 16 (2019): 2861. http://dx.doi.org/10.3390/molecules24162861.

Full text

Abstract:

The steady rise in the cancer burden and grim statistics set a vital need for new therapeutic solutions. Given their high efficiency, metallodrugs are quite appealing in cancer chemotherapy. This work examined the anticancer activity of an anti-trypanosomal ruthenium-based compound bearing the 5-nitrofuryl pharmacophore, [RuII(dmso)2(5-nitro-2-furaldehyde semicarbazone)] (abbreviated as RuNTF; dmso is the dimethyl sulfoxide ligand). The cytotoxicity of RuNTF was evaluated in vitro against ovarian adenocarcinoma, hormone-dependent breast adenocarcinoma, prostate carcinoma (grade IV) and V79 lun

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!